Notably, although there was no significant difference in NKA between control subjects and patients with any-stage lung cancer or early-stage lung cancer, the difference was highly significant between control subjects and patients with late-stage lung cancer in this study.
← all excerpts
Natural killer cell activity as a biomarker for the diagnosis of lung cancer in high-risk patients.
1
—
—